Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 35

Oncology

Pharma News and Updates for AstraZeneca, Supernus, and BMS

Notizia - Recent Pharma, Healthcare and Biotech Happenings

VBL Therapeutics’ VB-111 (ofranergene obadenovec); BMS’s mavacamten (Camzyos); Merck’s KEYTRUDA; AstraZeneca and Daiichi’s Enhertu; Pfizer/Biohaven’s VYDURA (rimegepant); AstraZeneca’s Ultomiris; Supernus’s Viloxazine (Qlebree); AbbVie’s Rinvoq

FDA Grants Fast Track Designation to VB-111 for Platinium-resistant Ovarian Cancer The FDA has given VBL Therapeutics’ VB-111 (ofranergene obadenovec), a targeted anticancer viral gene therapy, fast track designation for use as a viable therapeutic option in patients with platinum-resistant Ovarian Cancer. VB-111 is intended to target a wide spectrum of solid tumors, including ovarian cancer, using a dual mechanism. The strategy combines tumor vascular blockage with an anticancer immune response. Prior findings from a phase 1/2 trial showed that VB-111 coupled with paclitaxel was efficacious and safe in this patient population. Approximately half of the 21 pa...

Explore More...

AstraZeneca-Daiichi’s results; Novartis remunerates; Pfizer to acquire Therachon; Gilead & Goldfinch Bio collaboration

Ovarian Cancer

World Ovarian Cancer Day | 2019

Notizia

Notizia

Ovarian Cancer

Ovarian Cancer Treatment Drugs and Unmet Needs

the business cocktail lemborexant

The Business Cocktail

Notizia

Gene therapy

Can commoners afford to spend million dollars on GENE Therapy?

Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal

NASH

Notizia

gene therapy in oncology

Gene Therapy in Oncology: Innovation to Commercialization

The Business Cocktail

Inozyme Raises $67M; Shanghai Miracogen partners with Synaffix; EdiGENE raises $15M; Antengene announces its expansion

Gene Therapy in Oncology

The promising Pipeline for Gene Therapy In Oncology

Notizia

Multiple Sclerosis

Notizia

Multiple myeloma market

Multiple Myeloma Day

Notizia

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly